N° Verde Prenotazioni (rete fissa) 800.638638 | 02 99.95.99 (da cellulare)

GenetiCA Study

Evaluation of the genetic-molecular causes of out-of-hospital cardiac arrest: from patients to families – The GenetiCA Study

The aims are to define the exact prevalence of hereditary heart diseases in out-of-hospital cardiac arrest (OHCA) patients taking also into account gender, patient and OHCA characteristics, provincial settings and environmental pollution; to stratify the individualized arrhythmic risk of proband's family members to prevent further sudden cardiac deaths; to refine the classification of the variants of uncertain significance (VUS) on genes which can have the capability to drive to molecular alterations leading to arrhythmogenic hereditary heart diseases. A blood sample will be obtained during resuscitation from all the patients aged ≤50 years suffering an OHCA in Lombardy Region and then analysed for genetic variants possibly causative of cardiac diseases. Genetic data will be merged with patient, OHCA and post-resuscitation data thanks to the connection with LombardiaCARe, whilst pollution data will be retrieved from ARPA Lombardia for free. A genetic counselling and clinical-instrumental evaluation of the proband's first-degree family members will be performed if a pathogenic/likely pathogenic variant or a VUS will be disclosed during the genetic analysis.

Out-of-hospital cardiac arrest is one of the leading health emergencies, including in young people, with an incidence of up to 20 episodes per 100,000 inhabitants. In many cases of young patients (<=50 years old) the event is linked to structural or arrhythmogenic myocardial diseases of genetic origin. The studies available to date have demonstrated a genetic cause in 15-25% of cases, but they have analysed a limited number of genes or selected populations, such as survivors or patients who underwent autopsy.

The GenetiCA Study – promoted and conducted by the Fondazione IRCCS Policlinico San Matteo with the collaboration of AREU and funded by the Fondazione Regionale per la Ricerca Biomedica – is the first in the world to evaluate, in a homogeneous and cross-sectional manner, all victims of out-of-hospital cardiac arrest in an entire geographical area, the Lombardy Region, regardless of the outcome of the rescue.

The primary scientific objective is to define the prevalence of pathogenic or likely pathogenic (P-LP) variants associated with inherited heart diseases in patients under 50 years of age affected by out-of-hospital cardiac arrest.

From a clinical standpoint, the study aims to identify family members who carry the same genetic disorder, making it possible to start personalised diagnostic and therapeutic pathways to prevent further sudden cardiac deaths in the family.

Secondary objectives include the analysis of differences in prevalence by sex, provincial geographical distribution and pollution levels.

The protocol involves collecting a blood sample directly in the pre-hospital field by the Emergency Medical System (EMS). The blood sample is transferred to our Fondazione and analysed in the genetic laboratories of the Policlinico San Matteo evaluating the genes associated with genetically determined structural or arrhythmogenic heart diseases.

In the presence of pathogenic, likely pathogenic or uncertain-significance variants, first-degree relatives are offered free of charge pathway of genetic counselling and a complete clinical evaluation, including electrocardiogram and echocardiogram, with the aim of early identifying any at-risk conditions.

In Lombardy, an estimated 787 out-of-hospital cardiac arrests per year from medical causes are expected in people under 50, of whom 575 undergo cardiopulmonary resuscitation. The study expects to identify between 86 and 144 cases per year of pathogenic genetic variants associated with inherited heart diseases, enabling screening to be extended to families and concrete preventive action.

The study is funded by the Fondazione Regionale della Ricerca Biomedica (FRRB) with the Grant “Early Career Award – II edition”.

Scientific papers produced by the RESTART group on the GenetiCA study:

  • Morena A, Bendotti S, D'Ambrosio A, Marconi G, Stirparo G, Klersy C, Currao A, Primi R, UImanova L, Urtis M, Contri E, Palo A, Vicentini A, Savastano S, Grasso M, Arbustini E, De Luca L, Baldi E. Evaluation of genetic-molecular causes of out-of-hospital cardiac arrest - from patients to families: the GenetiCA study. Resusc Plus. 2026 May 4;29:101351. doi: 10.1016/j.resplu.2026.101351. PMID: 42199521; PMCID: PMC13199836.

Ultimo aggiornamento: 16/11/2026